Skip to main content
. Author manuscript; available in PMC: 2012 Jul 5.
Published in final edited form as: Oncogene. 2010 Sep 6;29(48):6367–6377. doi: 10.1038/onc.2010.364

Figure 5.

Figure 5

h7C10 treatment results in the activation of BAD and BAX. (a) Rh41 was treated with h7C10 for the indicated time and analyzed with immunoblots against t/p-BAD, as well as other phospho-proteins downstream of AKT signaling. (b) Rh41 was treated with h7C10 for 24 h and 1 µm staurosporine (+ctrl) for 4 h. Lysates were made and immunoprecipitated with an antibody against oligomerized BAX (active). Immunoblots were performed with a BAX antibody.